| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.4 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |